Reported Earlier, Amgen Says Repatha Cut Death Risk By 20% In High-Risk Heart Patients
In brief
Repatha cuts death risk by 20% in high‑risk adults without prior heart events.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.